Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2021 call → NOWe need to determine if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event ending the wait. The transcript discusses sales force expansion, hiring reps, and costs. Management mentions they are hiring sales reps, increasing pay, and that hiring picked up. They talk about rebuilding headcount. They also mention manufacturing inefficiencies, CE mark issues resolved, and some costs. But is there a specific waiting period where they are paying for something not yet earning? They are hiring reps, and those reps will take 6-9 months to become productive. They are paying salaries now, but the benefit (increased sales) hasn't arrived yet. They are also building out clean rooms, but that's more capital. The key is: do they describe it as a defined waiting period with a specific near-dated event? They say "we are growing our sales force" and "hiring picked up." They don't explicitly say "we are paying for reps who are not yet productive" as a current cost with a specific end date. They mention that reps take 6-9 months to ramp, but that's a general statement. They also mention manufacturing inefficiencies and transfers that are not yet efficient. But is there a single coherent situation? They are hiring many reps, and they are paying them now, but the sales will come later. However, they don't frame it as a "waiting period" with a specific event. They also mention that they are back to pre-COVID headcount and are ramping up. The question asks: "does management describe the company as CURRENTLY LIVING THROUGH A DEFINED WAITING PERIOD IT IS PAYING FOR OUT OF ITS OWN POCKET?" They are paying for sales reps who are being trained/onboarded, but they don't explicitly say "we are paying for them before they earn." They do say "we have 103 sales reps on payroll, with 6 more offers signed and 17 more territories being recruited." They are hiring, but they don't say that these reps are not yet earning. They might be productive quickly. Also, they mention "manufacturing inefficiencies" and "unfavorable product mix" but that's not a waiting period. They also mention "CE Mark issues resolved" and "back orders way down." They mention "Omniflow transfer" and "Syntel and Python" transfers that are not yet efficient.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.